Cargando…
Use of a Thrombin Fibrin Sealant in Reducing Blood Loss in Revision Hip Arthroplasty
We present a retrospective evaluation assessing the use of a novel fibrin sealant, Quixil(®) (OMRIX Biopharmaceuticals S.A.) in reducing blood transfusions following revision total hip replacement surgery. Forty four patients underwent revision total hip replacement surgery using Quixil(®), while 45...
Autores principales: | Ghoz, Ali, Al-Khateeb, Hesham, Rajkumar, Shanmugasundaram, Tavares, Shawn, Andrade, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645936/ https://www.ncbi.nlm.nih.gov/pubmed/27468998 http://dx.doi.org/10.2174/1874325001509010511 |
Ejemplares similares
-
Outcomes of Dual Modular Cementless Femoral Stems in Revision Hip Arthroplasty
por: Ghoz, Ali, et al.
Publicado: (2014) -
Fibrin-thrombin sealant does not reduce lymphocele formation in patients with inguinofemoral lymphadenectomy for vulvar cancer
por: Saner, Flurina AM, et al.
Publicado: (2019) -
Fibrin Sealant-Assisted Revision of the Exposed Ahmed Tube
por: Choudhari, Nikhil S., et al.
Publicado: (2015) -
Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel
por: Dwyer, Joseph F, et al.
Publicado: (2014) -
A Systematic Review and Meta-analysis of the Topical Administration of Fibrin Sealant in Total Hip Arthroplasty
por: Zhao, Zhihu, et al.
Publicado: (2018)